Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03984565 · ClinicalTrials.gov registry record · Phase 2

PAIN: a Project Assessing the Impact of a Novel Cannabinoid Product

A Phase 2 study of Chronic Pain, sponsored by Staci Gruber, Ph.D..

Recruiting
Registry status
Phase 2
Development phase
25
Enrollment target
1
Study location

NCT03984565 is a Phase 2 study of Chronic Pain that is actively recruiting participants, run by Staci Gruber, Ph.D.. The registered enrollment target is 25 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03984565, a Phase 2 study of Chronic Pain, is actively recruiting participants, sponsored by Staci Gruber, Ph.D..

RECRUITING
Registry status
Phase 2
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study is a clinical trial of a high-cannabidiol (CBD) sublingual product compared to placebo for 9 weeks in patients with chronic pain conditions. The study will assess the impact of CBD on chronic pain symptoms, conventional medication use, clinical state, quality of life, cognition, and biomarkers.

Conditions Studied

Chronic Pain

Interventions

  • DRUG Placebo
  • DRUG Cannabidiol

Study Locations (1)

Massachusetts

  • McLean Hospital - Belmont

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-06-27
Est. Completion 2026-09
Phase Phase 2

Sponsor

Staci Gruber, Ph.D.

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03984565

The ClinicalTrials.gov registry entry for NCT03984565 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The listed sponsor is Staci Gruber, Ph.D., which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03984565 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03984565 about?

NCT03984565 is a clinical study titled "PAIN: a Project Assessing the Impact of a Novel Cannabinoid Product". This study is a clinical trial of a high-cannabidiol (CBD) sublingual product compared to placebo for 9 weeks in patients with chronic pain conditions. The study will assess the impact of CBD on chronic pain symptoms, conventional medication use, clinical state, quality of life, cognition, and bioma...

What is the current status of trial NCT03984565?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2024-06-27. Estimated completion is 2026-09.

What conditions does trial NCT03984565 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT03984565?

The interventions under investigation include: Placebo (DRUG), Cannabidiol (DRUG).

Who is sponsoring clinical trial NCT03984565?

This trial is sponsored by Staci Gruber, Ph.D., which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03984565 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Pain

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.